Oxford Bioscience Partners

Oxford Bioscience Partners

Oxford Bioscience Partners

Suggest edits
Follow us
Also headquartered in Boston
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 12

Portfolio

Portfolio Tracker

Add info
Alantos Pharmaceuticals

Alantos Pharmaceuticals

Pharmaceuticals
Total funding
$20M in 2 rounds from 6 investors
By Oxford Bioscience Partners
$20M Series B in Mar, 2005
Exit Amgen Inc., Jun 6, 2007
AVEO Pharmaceuticals

AVEO Pharmaceuticals

Biotechnology
Total funding
$120.7M in 3 rounds from 8 investors
By Oxford Bioscience Partners
$42.7M Series B in Oct, 2003
Cambrios

Cambrios

Nanotechnology
Total funding
$30.4M in 3 rounds from 14 investors
By Oxford Bioscience Partners
$14.5M Series D in Nov, 2009
CardioFocus

CardioFocus

Biotechnology +2
Total funding
$109.2M in 7 rounds from 11 investors
By Oxford Bioscience Partners
$2.4M Debt financing in May, 2014
Claros Diagnostics

Claros Diagnostics

Health Care
Total funding
$4M in 1 rounds from 4 investors
By Oxford Bioscience Partners
$4M Series B in Mar, 2009
Exit OPKO Health, Inc., Oct 13, 2011
Dicerna Pharma

Dicerna Pharma

Health Care +1
Total funding
$258M in 4 rounds from 14 investors
By Oxford Bioscience Partners
$60M Series C in Jul, 2013
Glori Energy Inc.

Glori Energy Inc.

Clean Technology
Total funding
$20M in 2 rounds from 6 investors
By Oxford Bioscience Partners
$20M Series C in Jan, 2012
Seahorse Bioscience

Seahorse Bioscience

Biotechnology +1
Total funding
$15.4M in 2 rounds from 8 investors
By Oxford Bioscience Partners
$6M Series D in Mar, 2009
Tragara Pharma

Tragara Pharma

Biotechnology
Total funding
$5M in 1 rounds from 5 investors
By Oxford Bioscience Partners
$5M Series B in Apr, 2010

Want to see the complete list?
Go Pro!